Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan.
Gut. 2021 May;70(5):928-939. doi: 10.1136/gutjnl-2020-321217. Epub 2020 Oct 7.
Intraductal papillary mucinous neoplasms (IPMNs) are non-invasive precursor lesions that can progress to invasive pancreatic cancer and are classified as low-grade or high-grade based on the morphology of the neoplastic epithelium. We aimed to compare genetic alterations in low-grade and high-grade regions of the same IPMN in order to identify molecular alterations underlying neoplastic progression.
We performed multiregion whole exome sequencing on tissue samples from 17 IPMNs with both low-grade and high-grade dysplasia (76 IPMN regions, including 49 from low-grade dysplasia and 27 from high-grade dysplasia). We reconstructed the phylogeny for each case, and we assessed mutations in a novel driver gene in an independent cohort of 63 IPMN cyst fluid samples.
Our multiregion whole exome sequencing identified , a previously unreported genetic driver of IPMN tumorigenesis, with hotspot mutations in one of two codons identified in >50% of the analyzed IPMNs. Mutations in were significantly more prevalent in low-grade regions in our sequenced cases. Phylogenetic analyses of whole exome sequencing data demonstrated diverse patterns of IPMN initiation and progression. Hotspot mutations in were also identified in an independent cohort of IPMN cyst fluid samples, again with a significantly higher prevalence in low-grade IPMNs.
Hotspot mutations in occur at high prevalence in IPMNs. Unique among pancreatic driver genes, mutations are enriched in low-grade IPMNs. These data highlight distinct molecular features of low-grade and high-grade dysplasia and suggest diverse pathways to high-grade dysplasia via the IPMN pathway.
导管内乳头状黏液性肿瘤(IPMNs)是一种非浸润性的前体病变,可进展为浸润性胰腺癌,并根据肿瘤上皮的形态学特征分为低级别或高级别。我们旨在比较同一 IPMN 的低级别和高级别区域的遗传改变,以确定肿瘤进展的分子改变。
我们对 17 例同时存在低级别和高级别异型增生的 IPMN 组织样本进行了多区域全外显子组测序(76 个 IPMN 区域,包括 49 个来自低级别异型增生和 27 个来自高级别异型增生)。我们为每个病例重建了系统发育树,并在 63 例 IPMN 囊液样本的独立队列中评估了一个新的驱动基因中的突变。
我们的多区域全外显子组测序确定了,这是一种以前未报道的 IPMN 肿瘤发生的遗传驱动因素,在分析的 IPMNs 中超过 50%的两个密码子中都有热点突变。在我们测序的病例中,低级别区域的突变明显更为常见。全外显子组测序数据的系统发育分析表明了 IPMN 起始和进展的多种模式。在另一个独立的 IPMN 囊液样本队列中也发现了 中的热点突变,同样在低级别 IPMN 中更为常见。
中的热点突变在 IPMNs 中发生率很高。在胰腺驱动基因中独一无二的是, 突变在低级别 IPMNs 中更为丰富。这些数据突出了低级别和高级别异型增生的不同分子特征,并表明通过 IPMN 途径向高级别异型增生存在不同的途径。